Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll…
(Reuters) - About one in eight adults have taken a drug belonging to the GLP-1 class of…
(Reuters) - About one in eight adults have taken a drug belonging to the GLP-1 class of…
By Leroy Leo and Christy Santhosh (Reuters) -AbbVie expects a drop in sales volumes of its…
(Reuters) - The U.S. Food and Drug Administration on Friday gave accelerated approval for…
(Reuters) -Shares of Moderna fell 4% on Wednesday after a U.S. judge issued an order that…
By Puyaan Singh (Reuters) -Abbott Laboratories said on Tuesday the U.S. FDA has approved…
By Dietrich Knauth NEW YORK (Reuters) - Rite Aid, one of the largest U.S. pharmacy chains,…
By Patrick Wingrove and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration…
By Stine Jacobsen and Maggie Fick COPENHAGEN (Reuters) - Novo Nordisk's widely used…
FRANKFURT (Reuters) -German drugmaker Bayer said on Monday that it was amending its…
By Manas Mishra and Sriparna Roy (Reuters) -Biogen on Tuesday forecast flat 2024 product…
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.